TW221809B - - Google Patents

Info

Publication number
TW221809B
TW221809B TW080104434A TW80104434A TW221809B TW 221809 B TW221809 B TW 221809B TW 080104434 A TW080104434 A TW 080104434A TW 80104434 A TW80104434 A TW 80104434A TW 221809 B TW221809 B TW 221809B
Authority
TW
Taiwan
Application number
TW080104434A
Other languages
Chinese (zh)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of TW221809B publication Critical patent/TW221809B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW080104434A 1990-06-07 1991-06-06 TW221809B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53439790A 1990-06-07 1990-06-07

Publications (1)

Publication Number Publication Date
TW221809B true TW221809B (sr) 1994-03-21

Family

ID=24129867

Family Applications (1)

Application Number Title Priority Date Filing Date
TW080104434A TW221809B (sr) 1990-06-07 1991-06-06

Country Status (17)

Country Link
EP (1) EP0593464A1 (sr)
JP (1) JPH07116150B2 (sr)
KR (1) KR930700102A (sr)
CN (1) CN1058015A (sr)
AU (1) AU655428B2 (sr)
CA (1) CA2083957A1 (sr)
FI (1) FI925545A0 (sr)
HU (1) HUT64747A (sr)
IL (1) IL98387A0 (sr)
MA (1) MA22195A1 (sr)
MX (1) MX26167A (sr)
NZ (1) NZ238426A (sr)
PL (1) PL290587A1 (sr)
PT (1) PT97913A (sr)
TW (1) TW221809B (sr)
WO (1) WO1991018601A1 (sr)
ZA (1) ZA914322B (sr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0604529A1 (en) * 1991-09-19 1994-07-06 Smithkline Beecham Corporation Pyridine compounds for treating leukotriene-related diseases
IL106156A0 (en) * 1992-06-30 1993-10-20 Smithkline Beecham Corp Pyridinyl compounds
EP0649408A4 (en) * 1992-06-30 1995-06-21 Smithkline Beecham Corp METHOD FOR THE PRODUCTION OF PHENYLTHIOMETHYLPYRIDINYLALKENOATS.
DE4224402A1 (de) * 1992-07-21 1994-01-27 Schering Ag Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung
GR1001409B (el) * 1992-10-15 1993-11-30 Smithkline Beecham Corp Ενώσεις για την ?εραπευτική αγωγή ασ?ενειών που έχουν σχέση με λευκοτριένια.
ES2065234B1 (es) * 1992-10-27 1995-09-01 Smithkline Beecham Corp Compuestos para tratar enfermedades relacionadas con los leucotrienos.
US5643914A (en) * 1993-03-02 1997-07-01 Smithkline Beecham Corporation Pharmaceutical pyridine compounds
US5929096A (en) * 1996-02-29 1999-07-27 Smithkline Beecham Corporation Method for treating atopic dermatitis and contact dermatitis
EP0942903A1 (en) 1996-09-26 1999-09-22 Novartis AG Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity
DK2520654T3 (en) 2003-08-26 2017-05-01 Univ Colorado Regents Inhibitors of serine protease activity and their use in methods and compositions for the treatment of bacterial infections
WO2019244464A1 (ja) * 2018-06-22 2019-12-26 パナソニック株式会社 有機塩とこれを備えるヒドロキシラジカルセンサ及び検出メディア

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056619A (en) * 1975-09-08 1977-11-01 Warner-Lambert Company 1-Substituted-2-(2-pyridinyl)ethanone N-oxides

Also Published As

Publication number Publication date
AU8189691A (en) 1991-12-31
FI925545A7 (fi) 1992-12-07
PT97913A (pt) 1992-03-31
HUT64747A (en) 1994-02-28
HU9203867D0 (en) 1993-03-29
CA2083957A1 (en) 1991-12-08
FI925545L (fi) 1992-12-07
WO1991018601A1 (en) 1991-12-12
AU655428B2 (en) 1994-12-22
KR930700102A (ko) 1993-03-13
MA22195A1 (fr) 1992-04-01
FI925545A0 (fi) 1992-12-07
ZA914322B (en) 1992-06-24
CN1058015A (zh) 1992-01-22
NZ238426A (en) 1994-11-25
PL290587A1 (en) 1992-08-24
EP0593464A1 (en) 1994-04-27
JPH07116150B2 (ja) 1995-12-13
JPH05507492A (ja) 1993-10-28
IL98387A0 (en) 1992-07-15
EP0593464A4 (en) 1993-02-12
MX26167A (es) 1994-02-28

Similar Documents

Publication Publication Date Title
FR2662472B1 (sr)
DE4193233T (sr)
DE4191065T (sr)
JPH0490184U (sr)
DE4190587T (sr)
DE4190051T (sr)
DE4190781T (sr)
FR2669280B1 (sr)
DE4190102T (sr)
DE4092353T (sr)
DE4191921T (sr)
DE4193387T1 (sr)
FR2663058B1 (sr)
DE4191355T1 (sr)
DE4190411T1 (sr)
DE4193388T1 (sr)
AU6664390A (sr)
IN172129B (sr)
DE4191689T (sr)
DE4190252T (sr)
AU6585690A (sr)
AU8140291A (sr)
AU7829091A (sr)
AU7087091A (sr)
ECSM90396U (sr)